Stefan Vonhoff PhD

Stefan Vonhoff, Ph.D. is VP Chemistry&Manufacturing at NOXXON Pharma AG, Berlin, Germany, a biotech company developing Spiegelmers – enantiomeric aptamers – for various therapeutic indications in the oncology area.

Stefan holds a Ph.D. in chemistry from University College London and received post-doctoral training in the Department of Chemistry at the ETH Zurich. He joined NOXXON in 1999 to establish the manufacturing process for L-nucleoside phosphoramidites and pegylated L-RNA aptamers. Today, his main responsibility is to coordinate external manufacturing and QC/QP-release activities for starting materials, drug substances, parenteral drug products,s, and clinical trial supply.